Pharmazac was awarded the Salus Index 2016 Active Business Awards
November 2, 2023Pharmazac Sintetica & Rokitan Cooperations
November 2, 2023Pharmazac Lab acquires GMP certificates

Pharmazac announces that its state-of-the-art Research and Development Lab at its headquarters received by the Greek Ministry of Health a GMP manufacturing license (clinical batches) for under development medicinal products for human use and a GMP certificate for quality-control (QC) release.
Related News
November 2, 2023
We are investing in our new pharmaceuticals manufacturing site.
Pharmazac is working on its latest investment a new site of 10.000 sq.m for pharmaceuticals manufacturing, in the industrial zone of Keratea near Athens area . […]
November 2, 2023
Pharmazac launched the new product Zaolin/Vinorelbin
Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece. Zaolin/Vinorelbin is a chemotherapy drug used to […]
November 2, 2023
We are exhibiting and partnering
With Covid-19 on the way of most of our exhibiting activities, Pharmazac has joined in 2020 the largest pharmaceutical partnering events and has participated in more […]
November 2, 2023
We are becoming a manufacturer and key player in radiopharmaceuticals
We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]
